Updates with comments from UBS note

** Cochlear COH.AX slides as much as 14.1% to A$261.73; set for worst day since March 2020

** Stock at lowest level since November 2023

** Hearing implants maker reports HY underlying NPAT of A$206 mln ($206 mln), missing Visible Alpha consensus of A$209.3 mln

** Expects FY underlying net profit to be at lower end of A$410 mln-A$430 mln forecast range

** UBS says, "New expectations for being at lower end of profit guidance could cause concern or it could just be a blip if services revenue in fiscal 2026 can pick up again with new product launches"

** Expects single-digit decline in FY services revenue

** COH among worst performers on ASX 200 benchmark index .AXJO

** Stock, one of the priciest in the country, down ~9% YTD

($1 = $1.0000)

(Reporting by Himanshi Akhand and Roshan Thomas in Bengaluru)

((Himanshi.Akhand@thomsonreuters.com))